Zepp Health Corporation
ZEPP · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $2 | $4 | $6 |
| % Growth | -46.6% | -40.8% | -31.7% | – |
| Cost of Goods Sold | $1 | $2 | $3 | $5 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 38.5% | 26.2% | 19.4% | 20.9% |
| R&D Expenses | $0 | $0 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -25.9% | -8.6% | -9.9% | 1.5% |
| Other Income/Exp. Net | -$0 | -$0 | $0 | $0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | $0 |
| Tax Expense | $0 | -$0 | -$0 | $0 |
| Net Income | -$1 | -$0 | -$0 | $0 |
| % Margin | -41.6% | -8.8% | -7% | 2.2% |
| EPS | -136.64 | -7.84 | -10.84 | 5.52 |
| % Growth | -1,642.9% | 27.7% | -296.4% | – |
| EPS Diluted | -136.64 | -7.84 | -10.84 | 5.24 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -25.9% | -5.7% | -6.2% | 3.3% |